Bipartisan talks over a marijuana banking bill were “very productive” over the August recess, the office of the lead GOP Senate sponsor told Marijuana Moment, and a key Democratic chairman said an agreement on advancing the legislation is “imminent.”
Senate Banking Chair Sherrod Brown (D-OH) confirmed that lawmakers are closing in on a bipartisan agreement to move ahead with the legislation (PoliticoPro), which follows similar assurances from Senate Majority Leader Chuck Schumer last week.
Maryland canna retailers sold a record $92M of product during their second month of adult-use—that’s $2.8M per day—while Massachusetts hit the $5B milestone in canna sales after The Bay State generated consecutive record breaking months.
Medical cannabis patients saw an improved quality of life and lower pain, anxiety and depression after three months of use, a study shows and I can confirm, and that’s all before (potential) rescheduling allows for research that will help to demonstrate the efficacious agility of this magical plant.
Seismic Shifts
The news cycle of this past week hasn’t been lost on the forgotten tribe of canna bulls as the upside price action and massive volume awoke long-dormant animal spirits.
[total notional volume for the entire U.S plant-touching publicly traded universe was $18M last Monday. The last four sessions averaged more than $275M).
We used to contemplate what might happen if SAFE passed/ 280E went away/ stocks could list on major exchanges/ CPG M&A was back on the table/ institutions ungated/ MSOS trended on WSB/ there was insider buying and stock buybacks—but I’m not sure that anybody contemplated these catalysts potentially happening all at once.
[^ I’m not saying they all will happen bc real risks remain—DEA not playing ball, govt shutdown, stock market/ rates/ macro—and we still need to see where OH FL PA land, but the probability spectrum is adjusting through a rapid process of price discovery]
One of the most intriguing dynamics as we unpack this situation is the structural set-up, which could potentially turn nice into spice in short-order.
- Click here to get Cannabis Confidential delivered to your inbox daily.
The timing of last week’s leak into the barren wasteland of summer’s end + the (listed and naked) short base + potentially seismic catalysts + napkin math suggesting a 2-3X fundamental turn sans 280E = perhaps the single best set-up I’ve seen in my 34 years on Wall Street.
And some would say the real buyer’s haven’t even entered the room yet.
Channel checks suggest there’s been minimal to no institutional buying, which makes sense given, ex-TerrAscend, none of these stocks can be held at Wall Street banks (and presumably won’t be able to until SAFE Banking is passed). We’re also told that legacy funds and momo guys aren’t chasing after being burned so many times before.
Meanwhile short interest on U.S. cannabis ETF MSOS MSOS increased 4% coming into today and we continue to hear that a cabal of evil Canadian hedge funds have been pressing and defending their short bets after getting trapped by the late-August announcement.
[we obviously can’t confirm whether that’s true but worth noting MSOS traded ~$15 in December on speculation that only SAFE would pass before the wish-list was in play]
[note/caveat: I’ve been bullish on U.S cannabis for well over a decade]
[note/caveat: this isn’t a call for the day/ week/ at all and is catalyst-dependent]
In other news, three-in-five Floridians support cannabis legalization as their Supreme Court weighs the reform ballot initiative; Labor Day weekend gave a lift to U.S canna sales (+8.4% vs previous wknds; +6.4% YoY); MSO CEOs implored NY Governor Kathy Hochul to let them enter the state’s adult-use market as the NYS Senate gets involved; border sales see a 2X boost for most marijuana retailers across U.S; the first concert allowing on-site cannabis use will be held in Illinois this weekend; I’m gonna front-run that by enjoying some kind bud at the Jones Beach Sting show Friday night; we spy new insider buys at TerrAscend, ponder the potential Reddit crack, offer random thoughts on the current condition, say the quiet part out loud and delve into the latest wild canna rumor/ conspiracy theory making it’s way around the street.
All that, and more, just scroll down…
SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ PT Notional: $255M
Top Stories
- Cannabis banking deal ‘imminent’, Sherrod Brown says
- Marijuana Banking Bill Talks Were ‘Very Productive’ Over Recess, GOP Senate Sponsor’s Office Says, As Key Chairman Predicts ‘Imminent’ Agreement
- Maryland Marijuana Retailers Sell Record $92M In Products During State’s Second Month Of Adult-Use Legalization
- Three In Five Floridians Support Marijuana Legalization, New Poll Finds As State Supreme Court Weighs 2024 Reform Ballot Initiative
- Labor Day Provides Promising Cannabis Sales Lift
- Marijuana MSOs implore New York gov to let them enter state’s adult-use market
- NYS Senate to hold hearing on the state’s adult-use cannabis market
- Eastern Band of Cherokee Indians may legalize recreational marijuana — a first in North Carolina
- Marijuana reclassification won’t fix conflict between state, federal laws on pot
- Border sales a boost for most marijuana retailers across US
Market Stuff
MSOS short interest +6% overnight (reminder: we can’t reasonably track CSE-listed SI]
- 8/23: 10.77M
- 9/1: 11.46M (+6.4%)
- 9/5: 11.01M (-4%)
- 9/6: 11.62M (+6%)
I keep reminding myself to zoom out. What’s that mean? Maintain perspective…
…and stay objective. Cannabis bulls, such as myself, have a lot of wood to chop.
MSOS $8.80, which was the December low, has managed to halt the advances the last two sessions, largely bc these names are so short-term extended and they’re up against other technical lines across various horizons.
As discussed in real-time over on Twitter X Subs, there are going to be scares and air pockets from here-to-there no matter where the there takes us; we know it won’t come easy as the bulls and bears will battle at every level as adoption finally arrives.
Take a breath, remove emotions and remember, there’s no looking back.
Grassy Knoll
Anyone who’s followed this space for any meaningful amount of time would offer that there’s been an almost unnatural predilection to close/ print/ press these stocks lower day-after-day-after-day… (repeat 931 times).
We dove into the machination here; some stellar takeaway quotes:
"never seen anything like it,”
"being pressed to dangerous levels”
“only so far they can go before it blows up in their face”
A year and a half later, here we are; and while we genuinely don’t know who’s short what where, word on the street is that there’s been a funky flow-of-funds involving Canadian hedge funds routing naked short orders through European bourses, which evidently have loopholes that allow for such things.
It is difficult to know if that motherfucker is real but if so, one would expect sunlight to disinfect these names over time.
- Click here to get Cannabis Confidential delivered to your inbox daily.
Stems & Seeds
J-Dubs continues to do his thing at TerrAscend TSNDF.
Gonna Say the Quiet Part out Loud
Illinois Concert This Weekend Will Be State’s First To Allow On-Site Marijuana Consumption
/end
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
If you’d like to help Mission [Green] change federal cannabis policies, please click here.
CB1 has positions in / advises some of the companies mentioned and nothing contained herein should be considered advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.